New Delhi, Feb 10 (IANS) AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment for an additional indication.In its latest stock exchange filing, the drug company said that through this approval, “Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or rec…
Trending
- KD: The Devil 2026 Review: Dhruva Sarja’s Underworld Epic Is a Bold, Ambitious Saga
- Patriot (2026) Movie Review: Mammootty and Mohanlal’s Legendary Reunion Delivers a Gripping Surveillance Thriller
- Kara Movie Review: Dhanush Delivers a Gripping Slow-Burn Thriller You Cannot Miss
- Raja Shivaji (2026) Movie Review: Riteish Deshmukh’s Grand Epic Is a Majestic Tribute to the Warrior King
- Ek Din (2026) Review: A Heartwarming Love Story That Stays With You Long After the Credits Roll
- Alvida: The Last Goodbye Review — A Haunting Farewell That Lingers Long After the Credits
- Elra Kaaleliyatte Kaala Review: A Soulful Ode to Timelessness That Charms Despite Its Flaws
- Sugriva Movie Review (2026): A Gripping Emotional Thriller That Hits Hard